EXAGEN INC. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Exagen Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Exagen Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.59M, a 47.4% increase year-over-year.
  • Exagen Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$15.8M, a 54.7% increase year-over-year.
  • Exagen Inc. annual Operating Income (Loss) for 2023 was -$22.8M, a 50.4% increase from 2022.
  • Exagen Inc. annual Operating Income (Loss) for 2022 was -$46.1M, a 91.3% decline from 2021.
  • Exagen Inc. annual Operating Income (Loss) for 2021 was -$24.1M, a 58.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$22.8M +$23.2M +50.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$46.1M -$22M -91.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$24.1M -$8.88M -58.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$15.2M -$5.89M -63.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 -$9.3M -$4.42M -90.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$4.88M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.